Mackenzie Financial’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
26,286
+194
| +0.7% | +$9.48K | ﹤0.01% | 951 |
|
|
2025
Q1 | $1.33M | Buy |
26,092
+3,316
| +15% | +$169K | ﹤0.01% | 897 |
|
|
2024
Q4 | $1.03M | Buy |
22,776
+12,967
| +132% | +$585K | ﹤0.01% | 928 |
|
|
2024
Q3 | $364K | Buy |
9,809
+440
| +5% | +$16.3K | ﹤0.01% | 1107 |
|
|
2024
Q2 | $287K | Buy |
+9,369
| New | +$287K | ﹤0.01% | 1182 |
|
|
2023
Q3 | – | Sell |
-5,627
| Closed | -$233K | – | 1565 |
|
|
2023
Q2 | $233K | Sell |
5,627
-8,102
| -59% | -$336K | ﹤0.01% | 1278 |
|
|
2023
Q1 | $665K | Buy |
13,729
+7,800
| +132% | +$378K | ﹤0.01% | 942 |
|
|
2022
Q4 | $226K | Buy |
5,929
+1,168
| +25% | +$44.6K | ﹤0.01% | 1196 |
|
|
2022
Q3 | $239K | Buy |
+4,761
| New | +$239K | ﹤0.01% | 1177 |
|
|
2019
Q1 | – | Sell |
-7,060
| Closed | -$242K | – | 1295 |
|
|
2018
Q4 | $242K | Buy |
+7,060
| New | +$242K | ﹤0.01% | 1069 |
|
|
2016
Q4 | – | Sell |
-27,400
| Closed | -$384K | – | 712 |
|
|
2016
Q3 | $384K | Sell |
27,400
-110,800
| -80% | -$1.55M | ﹤0.01% | 530 |
|
|
2016
Q2 | $970K | Hold |
138,200
| – | – | 0.01% | 606 |
|
|
2016
Q1 | $890K | Buy |
138,200
+36,900
| +36% | +$238K | 0.01% | 531 |
|
|
2015
Q4 | $3.28M | Buy |
101,300
+5,000
| +5% | +$162K | 0.02% | 345 |
|
|
2015
Q3 | $2.57M | Buy |
96,300
+8,900
| +10% | +$238K | 0.02% | 378 |
|
|
2015
Q2 | $4.21M | Buy |
87,400
+32,100
| +58% | +$1.55M | 0.02% | 326 |
|
|
2015
Q1 | $3.37M | Buy |
55,300
+23,800
| +76% | +$1.45M | 0.02% | 354 |
|
|
2014
Q4 | $1.63M | Buy |
+31,500
| New | +$1.63M | 0.01% | 449 |
|